News

In an attempt to learn more about DNA enhancers, the Crocker group from EMBL Heidelberg performed an extensive study, published in Nature, on a specific enhancer in the model organism Drosophila melanogaster, a species of fruit fly.

Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences have unraveled potential mechanisms behind the healing power of extracellular vesicles and demonstrated their capacity to not only revive cells after a heart attack, but keep cells functioning while deprived of oxygen during a heart attack.

Researchers have found that a drug that activates the body's natural defenses by behaving like a virus may also make certain melanoma tumors visible to the immune system, enabling the cancer cells to be better targeted by immunotherapy.

Purdue University scientists have developed a new approach that involves applying machine learning concepts to the tandem mass spectrometry process to improve the flow of information in the development of new drugs.

A new BYU study indicates some significant public messaging should be communicated before any COVID-19 vaccines are made available in the US. And with vaccines potentially being approved by the end of the year or early next year, the clock is ticking.

NCI-MATCH precision medicine trial makes major contributions to the use of tumor gene testing to select treatment for patients. Newly published data has broad relevance in medicine, providing a roadmap for future precision medicine trials.

Hair follicle stem cells, which promote hair growth, can prolong their life by switching their metabolic state. In experiments conducted with mice, a research group active in Helsinki and Cologne has demonstrated that a protein called Rictor holds a key role in the process.

Moles stop growing when they reach a specific size due to normal interactions between cells, despite having cancer-associated gene mutations. This finding could help to develop novel ways to prevent skin cancer growth that can take advantage of normal cell growth mechanisms.

CORONAVIT will run for six months and involve more than 5,000 people to find out whether a ‘test-and-treat’ approach to correct people’s vitamin D deficiency during winter will reduce the risk and/or severity of COVID-19 and other acute respiratory infections.

Study finds that compressing cells, and crowding their contents, can coax them to grow and divide.